Search
Close this search box.

Global Allergy Awareness Rises, 40% Now Actively Avoid Disease-Trigger Products

Four in ten individuals worldwide now actively avoid products known to trigger allergic reactions, marking a significant 10% increase since 2018, according to a new Worldviews Survey by the Worldwide Independent Network of Market Research (WIN).

The survey, encompassing 35,515 people across 40 nations, reveals a growing global trend of heightened health consciousness and proactive allergen avoidance. This rise in preventative measures comes as the world observes World Allergy Day, emphasizing the importance of understanding and managing allergies. The survey demonstrates a consistent upward trend across demographics like age, education, and employment, with a slightly more pronounced difference between genders. 43% of women report avoiding allergens compared to 36% of men.

Significant geographical variations also exist. Nations like Morocco (69%), the US (55%), Argentina (52%), Brazil (52%), and India (52%) exhibit the highest allergen avoidance rates, exceeding 50%. Conversely, countries such as Japan (21%), South Korea (22%), Indonesia (22%), Thailand (23%), Finland (27%), and Germany (27%) show considerably lower rates, with less than 30% of respondents actively avoiding trigger items.

The increasing awareness reflects a global shift towards proactive health management, particularly concerning life-threatening reactions like anaphylaxis. While the World Allergy Organization (WAO) emphasizes the severity of anaphylaxis, improved access to treatment like epinephrine and auto-injectors, combined with increased awareness, offers hope for preventing such severe outcomes.

WIN International Association President Richard Colwell stressed the vital role of health education in preventing diseases. The observed global increase in allergen avoidance signals a growing awareness of personal health, transcending geographical boundaries and demographics. Colwell highlights the importance of continued education, early diagnosis, and treatment accessibility in mitigating preventable health risks such as anaphylaxis.

Share: